Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFátima Cardoso, Elżbieta Senkus, S. Kyriakides et al.|Annals of Oncology|2019Cited by 2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Fátima Cardoso, Eric P. Winer, N. El Saghir et al.|Annals of Oncology|2016Cited by 2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Fátima Cardoso, Eric P. Winer, Shani Paluch–Shimon et al.|Annals of Oncology|2020Cited by 1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Fátima Cardoso, E.P. Winer, Elżbieta Senkus et al.|Annals of Oncology|2018Cited by 1.2k
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapyShinji Ohno, Masakazu Toi|Breast Cancer Research and Treatment|2013Cited by 55